Interestingly, CHI3L1 has been reported to be overexpressed in many cancers and increased CHI3L1 level in serum seems to correlate with a poor prognosis in patients with metastatic cancer [16,17]. Here, CHI3L1 is linked to metastatic malignant neoplasm.